CARSON CITY, Nev. (KOLO) - Nevada Gov. Brian Sandoval has vetoed a bill that tried to control insulin prices by making them more transparent.
Senate Bill 265 would have created a list of medications needed to treat diabetes and to require manufacturers to give advance notice on price increases on those drugs. There were also requirements to make the drug companies and other groups more transparent.
Sandoval lauded the idea of making health care more affordable. But he warned in the message vetoing the bill it could have unintended consequences of restricting access to health care and making it less affordable. He said manufacturers or distributors could have an incentive to manipulate the insulin supply and make it less affordable.
Sandoval also said the bill could face legal challenges if approved.
Senate Majority Leader Aaron D. Ford issued this statement:
“With this veto, the Governor put the interests of major pharmaceutical companies ahead of one million Nevadans who are diabetic or pre-diabetic. Insulin is a life-saving drug that too many Nevadans simply can’t afford because of outrageous and inexplicable price hikes.
"Senate Bill 265 had significant bipartisan support because it would have finally lifted the shroud and shined some light on the skyrocketing costs of insulin. Tonight, one million Nevadans and their families have a reason to be disappointed in their state government.”